Rating History for Sutro Biopharma (STRO) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/28/2026 | Lukas Shumway | New Coverage | Overweight (N/A) |
56.00 (N/A) |
27.38 (22.88) |
-16.44% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/28/2026 | Lukas Shumway | New Coverage | Overweight (N/A) |
56.00 (N/A) |
27.38 (22.88) |
-16.44% | Details |